FATE THERAPEUTICS INC (FATE) › RevenueFATE THERAPEUTICS INC (FATE) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $4.40M2017: $4.11M2018: $4.74M2019: $10.68M2020: $31.43M2021: $55.85M2022: $96.30M2023: $63.53M2024: $13.63M2025: $6.65M$6.65M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$6.65M-51.2%2024$13.63M-78.5%2023$63.53M-34.0%2022$96.30M+72.4%2021$55.85M+77.7%2020$31.43M+194.3%2019$10.68M+125.3%2018$4.74M+15.4%2017$4.11M-6.7%2016$4.40M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share